论文部分内容阅读
目的:探讨基本药物招投标政策的实施现状和完善对策。方法:通过解读国家基本药物招投标政策,着眼于基本药物招投标的实施现状,分析当前基本药物招投标实际操作中存在的问题。结果:国家基本药物招投标政策在推行过程中成本与价格倒挂的尴尬局面,使得一部分企业不得不退出竞标,百姓无法得到真正的实惠。结论:在基本药物招投标实施的过程中,平衡质量与价格的关系,为百姓提供质量优先、价格合理的药物,才有可能真正缓解百姓“看病难,看病贵”的问题。
Objective: To discuss the status quo and countermeasures of implementing the bidding and tendering policy of essential drugs. Methods: By interpreting the national bidding policy of essential drugs and focusing on the implementation status quo of bidding and bidding for essential drugs, the problems existing in the actual operation of current bidding and bidding of essential drugs were analyzed. Results: The embezzlement of cost and price upside down in the process of national basic medicine bidding and tendering policy made some enterprises have to withdraw from the bidding and the people could not get the real benefit. Conclusion: During the implementation of bidding and bidding for essential drugs, it is possible to really balance the problem of “seeing a doctor hard and seeing a doctor expensive” by balancing the relationship between quality and price and providing people with quality-first and reasonably priced medicines.